Comorbidity influence in observational studies: Why ignore the real world?

Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5792. doi: 10.1002/pds.5792.

Authors

Victor A Kiri¹, Maurille Feudjo -Tepie²

Affiliations

¹ Market Access Consulting RWE & Analytics, Fortrea, Berkshire, UK.
² RWE & Digital sciences Head of Global RWE & Digital sciences, UCB, Berkshire, UK.

PMID: 38629241
DOI: 10.1002/pds.5792

No abstract available

MeSH terms

Comorbidity*
Humans